SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-17-006696
Filing Date
2017-11-01
Accepted
2017-11-01 16:07:10
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 a2233667zs-3.htm S-3 261134
2 EX-4.2 a2233667zex-4_2.htm EX-4.2 481466
3 EX-4.3 a2233667zex-4_3.htm EX-4.3 434292
4 EX-5.1 a2233667zex-5_1.htm EX-5.1 19337
5 EX-12.1 a2233667zex-12_1.htm EX-12.1 34176
6 EX-23.1 a2233667zex-23_1.htm EX-23.1 4028
7 G712315.JPG g712315.jpg GRAPHIC 8217
  Complete submission text file 0001047469-17-006696.txt   1246839
Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-221266 | Film No.: 171168992
SIC: 2834 Pharmaceutical Preparations